Desmoglein-1 Antibody [PE]
Novus Biologicals, part of Bio-Techne | Catalog # AF944P

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Western Blot
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Desmoglein‑1 extracellular domain
Glu50-His545
Accession # Q02413
Glu50-His545
Accession # Q02413
Specificity
Detects human Desmoglein‑1 in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross‑reactivity with recombinant human (rh) Desmoglein-2 is observed and less than 1% cross-reactivity with rhDesmoglein-3, rhDesmoglein-4, and recombinant mouse Desmoglein-1 alpha is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Desmoglein-1 Antibody [PE]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Desmoglein-1
Alternate Names
CDHF4, Desmoglein1, DSG1
Gene Symbol
DSG1
Additional Desmoglein-1 Products
Product Documents for Desmoglein-1 Antibody [PE]
Product Specific Notices for Desmoglein-1 Antibody [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...